Navigation Links
Obama’s Bioethics Commission to meet in D.C.
Date:7/27/2012

WASHINGTON, D.C. The Presidential Commission for the Study of Bioethical Issues will hold its tenth public meeting on August 1-2, 2012.

The Commission will continue its work in the following areas:

Genomics and Privacy:

Since January 2011 the Commission has been following the pressing problems raised by the emergence of whole genome sequencing as an addition to clinical care and genetic research. The Commission's genomics project seeks to outline many of the key issues surrounding how to reconcile an individual's need for privacy, consent, and respect with the need for gathering data from many individuals to advance discoveries to benefit the common good.

At this meeting the Commission will hear from speakers on a range of topics related to the privacy of and access to genomic data. For example, Latanya Sweeney, Ph.D. of Harvard University and Sonia Suter, M.S., J.D. of George Washington University will discuss how technology is changing views of genomic privacy; and Ken Chahine, Ph.D., J.D. of Ancestry, DNA and Laura Lyman Rodriguez, Ph.D. of the National Human Genome Research Institute will present on the protection of private and public genomic databases.

There will be substantial Member discussion and deliberation as this is the last meeting before the Commission releases its report with recommendations. The Commission expects to deliver a report on genomics and privacy in fall 2012.

Medical Countermeasures for Children:

At the request of Health and Human Services Secretary Kathleen Sebelius, the Commission is conducting a careful and transparent review of the ethical considerations of conducting clinical trials of medical countermeasures with children. The Commission is examining whether the U.S. government should do research that could cause harm to protect children from high consequence events with a low or unknown likelihood of happening. The Commission's report will include the ethical considerations of conducting a pre- and post-event study of an anthrax vaccine as a component of treatment for children exposed to weaponized anthrax.

The Commission will hear from subject matter experts including: David Resnik, J.D., Ph.D. of the NIH, Neal Halsey, M.D. of the Johns Hopkins School of Medicine, and Ruth Berkelman, M.D. of Emory University on the topic of considering individual risk versus Societal Benefit in assessing pediatric research. In addition, the Commission will hear from Paul B. Thompson, Ph.D. of Michigan State University, Richard Gorman, M.D. from the HHS Office of the Assistant Secretary for Preparedness and Response, and from Thomas A. Moore, M.D., F.A.C.P., Chair of the FDA Anti-Infective Drug Advisory Committee about what scientific, medical, and public health information is needed to facilitate decision-making for pediatric research on medical countermeasures.


'/>"/>

Contact: Hillary Wicai Viers
Hillary.Viers@bioethics.gov
202-233-3960
Presidential Commission for the Study of Bioethical Issues
Source:Eurekalert

Related biology news :

1. Synthetic Biology Scorecard finds federal agencies responding to bioethics report
2. Bioethics for Beginners: 60 Cases and Cautions from the Moral Frontier of Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/27/2016)... , Jan. 27, 2016  Rite Track, Inc. ... in West Chester, Ohio announced ... winning service staff, based in Austin, Texas ... and ability to provide modifications, installations and technical support ... , CEO of PLUS, commented, "PLUS has provided world ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized ... small to find new ways to ensure data security ... iOS and Android that ties ... biometrics, transforming it into a hardware authorization token. Customer ... swipe their fingerprint on their KodeKey enabled device to ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... , ... February 04, 2016 , ... ... and leading supplier of Semantic Graph Database technology has been recognized As “ ... ” by Corporate America Magazine. , “At Corporate America, it’s our priority to ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology: